HealthDay: Immunotherapy drug did not increase adverse surgery events
A University of Cincinnati study found administering an immunotherapy drug before surgery for oral cavity cancer did not lead to increased rates of complications during and after surgery.
HealthDay featured the research, recently published in JAMA Otolaryngology - Head & Neck Surgery, that evaluated outcomes during and after surgery when patients with head and neck cancer were given the immunotherapy drug pembrolizumab prior to surgery.
"What we found was that patients who received preoperative treatment with immunotherapy did not have an increase in morbidities around the time of surgery,” said Alice Tang, MD, first author on the study, assistant professor of clinical otolaryngology in UC’s College of Medicine, a UC Health physician and a University of Cincinnati Cancer Center member.
Featured photo at top of Alice Tang, MD, center, with patient. Photo provided by UC Health.
Related Stories
UC COVID-19 studies awarded $425K
April 15, 2020
Understanding that time was of the essence in combating this highly infectious disease, UC and its College of Medicine’s Office of Research conducted a rapid review and distribution of $425,000 in novel pilot grants to researchers, focusing on eradicating the disease.
Educational breast cancer event focuses on empowerment
Event: November 3, 2018 9:00 AM
"Beyond Breast Cancer: The Path to Empowerment” is an educational event for breast cancer survivors, their families and the community; it will be held from 9 a.m. to 3 p.m. Saturday, Nov. 3, at the Kingsgate Marriott Conference Center, 151 Goodman Drive.
Yahoo News: Five Black UC faculty members receive National...
September 8, 2020
Five African-American researchers and healthcare professionals on UC’s medical campus have received sizable grants from the National Institutes of Health during the past 18 months. The faculty members were interviewed by WCPO to help showcase innovation and the diverse voices and perspectives they bring as the healthcare community attempts to ease health disparities in communities of color in Cincinnati and beyond.